STOCKHOLM, SWEDEN / ACCESSWIRE / January 31, 2024 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB (publ) (FN STO:ALZCUR), a pharmaceutical company that develops candidate drugs for CNS diseases, focusing on

PALO ALTO, CA / ACCESSWIRE / January 31, 2024 / Bioz, Inc., a leading AI software company based in Silicon Valley, is excited to announce its partnership with Larodan, a

LONDON, UK / ACCESSWIRE / January 31, 2024 / Ecora Resources PLC (LSE:ECOR)(TSX:ECOR) issues the following trading update for the period 1 October 2023 to 31 December 2023. This update

LONDON, UK / ACCESSWIRE / January 31, 2024 / Ecora Resources PLC (LSE:ECOR)(TSX:ECOR) issues the following trading update for the period 1 October 2023 to 31 December 2023. This update

Ondine Biomedical demonstrated that photodisinfection does not harm the nasal microbiomeVANCOUVER, BC / ACCESSWIRE / January 31, 2024 / Research presented by Canadian life sciences company, Ondine Biomedical Inc. (“Ondine

LONDON, UK / ACCESSWIRE / January 31, 2024 / Ecora Resources PLC (LSE:ECOR)(TSX:ECOR) announces that it has entered into an amendment and extension of its $150 million revolving credit facility

LONDON, ENGLAND / ACCESSWIRE / January 31, 2024 / Argo Blockchain plc (“Argo” or “the Company”), a global leader in cryptocurrency mining (LSE:ARB)(NASDAQ:ARBK), announces that it has issued 154,475 new

Block Admission ReturnMANCHESTER, UK / ACCESSWIRE / January 31, 2024 / THE PEBBLE GROUP PLCName of applicant:The Pebble Group PlcName of scheme:The Sharesave PlansPeriod of return:From:31 July 2023To:31 January 2024Balance